These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22845339)

  • 1. How does use of a prescription monitoring program change medical practice?
    Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
    Pain Med; 2012 Oct; 13(10):1314-23. PubMed ID: 22845339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does use of a prescription monitoring program change pharmacy practice?
    Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
    J Am Pharm Assoc (2003); 2013; 53(3):273-81. PubMed ID: 23699676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doctor and pharmacy shopping for controlled substances.
    Peirce GL; Smith MJ; Abate MA; Halverson J
    Med Care; 2012 Jun; 50(6):494-500. PubMed ID: 22410408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department.
    Weiner SG; Griggs CA; Mitchell PM; Langlois BK; Friedman FD; Moore RL; Lin SC; Nelson KP; Feldman JA
    Ann Emerg Med; 2013 Oct; 62(4):281-9. PubMed ID: 23849618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribers and pharmacists requests for prescription monitoring program (PMP) data: does PMP structure matter?
    Fleming ML; Chandwani H; Barner JC; Weber SN; Okoro TT
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):136-42. PubMed ID: 23688495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
    Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
    Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician perspectives on a pilot prescription monitoring program.
    Barrett K; Watson A
    J Pain Palliat Care Pharmacother; 2005; 19(3):5-13. PubMed ID: 16219606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of objective data to identify risk for medication misuse and abuse: the inconsistency score.
    Hamill-Ruth RJ; Larriviere K; McMasters MG
    Pain Med; 2013 Dec; 14(12):1900-7. PubMed ID: 23947737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006.
    Katz N; Panas L; Kim M; Audet AD; Bilansky A; Eadie J; Kreiner P; Paillard FC; Thomas C; Carrow G
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):115-23. PubMed ID: 20014166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine.
    Pradel V; Frauger E; Thirion X; Ronfle E; Lapierre V; Masut A; Coudert C; Blin O; Micallef J
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):36-43. PubMed ID: 19040199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-medical use and abuse of commonly prescribed medications.
    Riggs P
    Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' perceptions of doctor shopping in West Virginia.
    Shaffer EG; Moss AH
    W V Med J; 2010; 106(4 Spec No):10-4. PubMed ID: 21932747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of prescribing - the Rhode Island prescription monitoring program.
    Cordy C; Kelly P
    R I Med J (2013); 2013 Nov; 96(11):36-7. PubMed ID: 24187677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics.
    Wilsey BL; Fishman SM; Gilson AM; Casamalhuapa C; Baxi H; Zhang H; Li CS
    Drug Alcohol Depend; 2010 Nov; 112(1-2):99-106. PubMed ID: 20566252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of prescription monitoring programs on chronic pain management.
    Wang J; Christo PJ
    Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research.
    Worley J
    Issues Ment Health Nurs; 2012 May; 33(5):319-28. PubMed ID: 22545639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A statewide prescription monitoring program affects emergency department prescribing behaviors.
    Baehren DF; Marco CA; Droz DE; Sinha S; Callan EM; Akpunonu P
    Ann Emerg Med; 2010 Jul; 56(1):19-23.e1-3. PubMed ID: 20045578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric Prescribers' Experiences With Doctor Shoppers.
    Worley J; Johnson M; Karnik N
    J Am Psychiatr Nurses Assoc; 2015; 21(5):309-18. PubMed ID: 26511432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.